Altimmune, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Altimmune, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2024.
  • Altimmune, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $100K, unchanged year-over-year.
  • Altimmune, Inc. annual Operating Lease, Payments for 2023 was $500K, unchanged from 2022.
  • Altimmune, Inc. annual Operating Lease, Payments for 2022 was $500K, unchanged from 2021.
  • Altimmune, Inc. annual Operating Lease, Payments for 2021 was $500K, a 25% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $100K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $100K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $500K $100K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $500K $181K +$73.6K +68.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 $426K $100K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $426K $119K +$22.1K +22.8% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $404K $100K +$4.29K +4.48% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $400K $108K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 $100K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $96.8K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $95.7K +$51.5K +117% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q1 2019 $44.2K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.